Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted radiotherapy for chemotherapy resistant neuroblastoma with I-131 MIBG
jRCTs041180041Completed
- Start
- Oct 2009
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta-minus Emitters → Radiopharmaceuticals, Gamma Emitters → Radiopharmaceuticals
- Countries
- 1
01
Overview
Open-label trial of Iobenguane I-131 in neuroblastoma (2 arms). Primary endpoints: Antitumor effect, Prognosis and 1 more. Started Oct 2009; status: completed.
02
Drugs
Iobenguane I-131
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on jRCTs041180041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180041.